乳がん
レジメン名をクリックするとレジメンの投与スケジュールが閲覧できます。
最終更新日:2023年10月2日
- BRST-101:Trastuzumab単剤
- BRST-102:adj Trastuzumab単剤
- BRST-103:AC療法
- BRST-105:EC療法
- BRST-106:FEC75
- BRST-107:FEC100
- BRST-108:Classical CMF
- BRST-109:weekly PTX80
- BRST-110:weekly PTX100
- BRST-111:DTX75
- BRST-112:DTX60
- BRST-113:TC療法
- BRST-114:VNR
- BRST-115:CPT-11
- BRST-116:Cape単剤/Cape+Lapatinib
- BRST-117:S-1単剤
- BRST-119:GEM
- BRST-120:GT療法
- BRST-121:triweekly Nab-PTX
- BRST-122:Eribulin
- BRST-123:Bv+wPTX
- BRST-124:PER+HER+DTX75
- BRST-125:PER+HER+wPTX80
- BRST-126:PER+HER
- BRST-127:T-DM1
- BRST-129:PER+HER+Eribulin
- BRST-130:PER+HER+VNR
- BRST-131:dose-dense AC療法
- BRST-132:TCH療法
- BRST-133:dose-dense PTX療法
- BRST-134:dose-dense EC療法
- BRST-135:TCHP療法
- BRST-136:Atezolizumab+nab-PTX
- BRST-137:T-DXd
- BRST-139:Pembrolizumab+CBDCA+GEM
- BRST-140:Pembrolizumab+wCBDCA+wPTX
- BRST-141:Pembrolizumab+EC
- BRST-142:Pembrolizumab+AC
- BRST-143:adjvant Pembrolizumab
- BRST-144:Pembrolizumab+CBDCA(ALC5)+PTX